The Role That Oncotarget Plays In The Medical Research Community

Oncotarget is an online medical journal that was first published by Impact Journals, LLC in 2010. It has become very popular as it publishes the latest medical research on a weekly basis as well as being open access. Oncotarget was co-founded by Andrei V. Gudkov and Mikhail Blagosklonny who both work at the Roswell Park Cancer Institute in Buffalo, New York. They are also the co-editors-in-chief of Oncotarget. Follow Oncotarget on Twitter.

For the first six years of Oncotarget’s life it was focused on Oncology, the area of medicine that both Blagosklonny and Gudkov have their Doctorates in. In 2017 the medical journal became a multidisciplinary journal by beginning to publish research in other fields like Metabolism, Cardiology, Endocrinology, and other areas. This helps to fulfill one of Oncotarget’s goals which is to bring down the walls that exist between different medical disciplines which will foster deeper and more comprehensive research. They also want to make the latest in medical research broadly and quickly available which is why they publish weekly. The ultimate goal of the people behind Oncotarget is playing a part in ending disease.

The research papers that are published in Oncotarget are often cited by other researchers. This has led to this medical journal having a very high impact factor as measured by Journal Citation Reports. One recent and highly cited research paper was about the health effects of e-cigarettes which have grown highly popular over the last several years. While many people think they’re safer than conventional cigarettes as it turns out they too cause a host of diseases and health problems according to the research. Visit his profile on Google Scholar.

In the last four years, four members of Oncotarget and its sister publications Oncoscience and Gerotarget have won the prestigious industry award named Breakthrough Prize. These four are Stephen J. Elledge, Alexander Varshavsky, Bert Vogelstein, and Michael N. Hall. Furthermore, Oncotarget is a sponsor of the highly anticipated Gordon Research Conference which will be taking place July 9-14, 2017 at the University of New England in Biddeford, ME.

How Sites Like Oncotarget Help Research

Examples of research that can help prove useful include recent breakthroughs in medicine, such as the idea that blood vessel growing cells can also create tumors. Access to this recent information makes a difference for reporters who want to share this information with accuracy. Because the success of an academic grade could depend on the quality of the sources used, it is helpful for students to have this information as well. Visit Oncotarget’s profile page at Facebook.

No matter what the health issue, there is no denying that research journal sites like Oncotarget help provide valuable research information. In a world where it often seems like reliable sources are constantly competing with other sources, it helps to know that these sites exist. Using a source if this type to help back up professional or academic research will help offer you success.

One effect of having so much information on the Internet is the need to discern which sources are the most beneficial. As such, scientific journals rank among some of the top sources to use. They are trusted by experts within the field and more likely to be given serious attention.

Another helpful use of such information is finding content for article or blog websites that require accurate information. These sites can help provide ideas that webmasters might need for valuable content. Because you can trust the information from these sites, you are much more likely to have quality content that others want to read.

Know more: https://www.researchgate.net/journal/1949-2553_Oncotarget

When you use these types of reliable sources for whatever your need, you can have confidence in the quality of information that you receive.

Eric Lefkofsky Contribution Towards Cancer Care

Eric Lefkofsky is an accomplished tech entrepreneur who has earned his name and title through the big names he has started and run. The successful tech guru is also throwing his contribution in the health sector too, specifically in the care of Cancer. Through Tempus, Eric has used his tech skills to come up with software that will help physicians in the health care to offer quality personalized care services to cancer patients.

Tempus is an innovative health care company that was founded to help provide quality health care services in the health industry. The company is involved in the collection and analyzing of data derived from other cancer patients and stored in a database. Thanks to a centralized database system, physicians can save a lot of time that would have otherwise been wasted carrying out research and concentrate on offering quality care to their patients.

Apart from technology and innovation, Eric Lefkofsky has also been involved in writing. Taking up this skills from his formative years in college he has authored a book that highlights how technology can be used to overcome challenges faced in the business industry. The book is a comprehensive manual for any business or institution that is planning to be competitive in the market.

Eric Lefkofsky is also a philanthropist in nature. He contribution includes both monetary terms and in kind. Two institutions that have been lucky to enjoy Eric’s donations include Steppenwolf Theatre and Lurie Children’s Hospital of Chicago. Erick additionally runs a foundation that called the Lefkofsky Family Foundation that supports a lot of schools and businesses under it.

Even as chronic diseases continues terrorizing families both financially and economically, Eric Lefkofsky is redefining hope giving them something to hope for. Through Tempus cancer patients can get customized care as the solid software developed by Eric helps analyze different solutions and providing one that is effective to theirs. Eric ha also spread the solutions to include other hospitals and organization such as Mayo Clinic. It’s just a matter of years, and the world care of cancer will be accessible and personalized to all thanks to Eric Lefkofsky and learn more about Eric.

More visit: https://www.tempus.com/about-us/